Linoleate-pazopanib conjugation as active pharmacological ingredient to abolish hepatocellular carcinoma growth
Ke Wang(Zhejiang Chinese Medical University), Wen‐Lung Ma(Asia University), Pei‐Yin Liao(China Medical University), Cian-Ru Yang(China Medical University), Najim Akhtar(University of Calgary), Yao‐Ching Hung(China Medical University), Yang‐Chang Wu(Kaohsiung Medical University), Hsueh‐Chou Lai(China Medical University), Wei‐Chun Chang(China Medical University), Ping‐Ching Wu(National Cheng Kung University Hospital), Yuting Su(South China Agricultural University)
Cited by 4
Related Papers
Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
|Gastroenterology|2008|253
Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor
|Hepatology|2008|207
Androgen Receptor Promotes Hepatitis B Virus–Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription
|Science Translational Medicine|2010|198
Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis
|Endocrine Related Cancer|2014|188